CORRECTION: VIA SMS group AS interim consolidated financial statements for the first six months of 2018

September 5, 2018, 10:47 pm

≫ Next: Walmart’s T-Shirt Homage To Mass Murder – OpEd

≪ Previous: Nicox Announces Intention to Conduct a Registered Offering on NASDAQ in the United States

$

0

0

Correction: Previously published interim consolidated financial statements of VIA SMS group AS for the first 6 months of 2018 includes cash and balances of VIA Payments UAB clients at Lithuanian Central Bank in amount of EUR 3 123 900. As a result of correction clients funds are represented as "Off balance sheet items". The correction affects consolidated statement of financial position, cash flow statement and notes. VIA SMS group AS repeatedly publishes interim financial report for the first 6 months of 2018.

During the period from 1 January 2018 to 30 June 2018, VIA SMS group AS operations were successful; the Group has closed the reporting period with a net turnover of EUR 10 493 305 and corresponding 9.7% increase in comparison with the same period in 2017. The largest net turnover growth is reached in Sweden. During the first six months of 2018 the Group has reached EBITDA of 2 251 091 EUR, ensuring the net profit of 1 251 708 EUR.

During the reporting period, significant growth was reached by the subsidiary operating in Sweden. Due to the optimization of the product portfolio based on the deep analysis of customer needs, the Swedish subsidiary experienced 28% growth in the net portfolio if compared to the last 12 months. Subsidiary in Poland, on the other hand, has experienced a slight decrease in the net turnover. Newly established subsidiary in Romania has shown stable operations and is currently focusing on strengthening its positions in the Romanian consumer lending market. Latvian subsidiary has also experienced growth following new product launch, as well as growing demand for payment card with credit line SAVA.card.

**VIA SMS group AS**

VIA SMS group is an alternative financial services provider operating across Europe. The company has been operating under several brands - VIA SMS, SAVA.card, VIAKREDIT, VIA CONTO, VIALET - and is offering consumer loans with a maturity term up to 24 months.   

During the first six months of 2018, the Group has mainly focused on strengthening its positions in existing markets where it is providing consumer lending services - Latvia, Sweden, Poland, Czechia, Spain, and Romania. The Group also intensively developed peer to peer lending platform VIAINVEST by promoting it in the public environment and attracting new investors.

The Group has also started an intensive development phase for the digital banking product VIALET that has acquired the Lithuanian electronic money institution license in 2017. It is planned to launch VIALET publicly in the second half of 2018.

         Viktorija Ratačova
         Chief Financial Officer
         VIA SMS Group AS
         Phone: +371 66102924
         E-mail: viktorija.ratacova@viasmsgroup.com Reported by GlobeNewswire 2 hours ago.

---

Walmart’s T-Shirt Homage To Mass Murder – OpEd

September 5, 2018, 11:00 pm

≫ Next: Verona Pharma Announces Publication of Key Paper on RPL554 in COPD in the European Respiratory Journal

≪ Previous: CORRECTION: VIA SMS group AS interim consolidated financial statements for the first six months of 2018

$

0

0

By Mari-Ann Kelam*

On Aug. 23, the European Day of Remembrance for Victims of Totalitarian Regimes, Estonia opened a new memorial for all victims of communism. The 30,000 square foot structure in Tallinn is dedicated to the people of Estonia who suffered under the terror inflicted by the Soviet Union. The names of 22,000 people who were murdered or never returned home from the inhumane conditions in Siberia are inscribed on the memorial’s plaques. Now, after the passage of so much time, many families finally have place to mourn their lost loved ones, to pray, to place flowers and candles. Considering the lighthearted treatment afforded communism by many in the West, these reminders remain much-needed.

The Day of Remembrance marks the infamous Molotov – Ribbentrop Pact on August 23, 1939, which divided Europe between Hitler and Stalin and paved the way to World War II.  Much of the world has forgotten that these dictators remained allies until Germany invaded the USSR in late 1941.  Many do not realize that both national socialism, or Nazism, and communism shared the idea that everything was permissible for the good of the cause – everything from martial law to confiscations, occupations, arrests, torture and murder.

The crimes of Stalin have sometimes been excused because he ultimately fought against Nazi Germany.  Soviet crimes against humanity were not even mentioned at the Nuremburg trials. Sadly, the huge American contribution to winning the war and rebuilding the western part of Europe has been ignored or forgotten as well. But all this means that the crimes of Stalin and his communist successors have not been judged properly nor have the millions of victims and their survivors received proper recognition or any assurance that history will not repeat itself. Stalin and Hitler had much blood on their hands – basically two sides of one filthy coin – yet only one side seems to be etched into the memory of mankind.

And because so far there has been no judgment of Russia’s Soviet past, the unfortunate Russian people have ended up with an authoritarian leader who falsifies the past, glorifies Stalin and his era, ignores rule of law, invades his neighbors, and eliminates those who dare to criticize or oppose him. In 2002, Alexander Yakovlev, in his book “A Century of Violence in Soviet Russia“ warned that Russia will never be a normal country until it acknowledges and comes to terms with the crimes of its Soviet past.

It is a task left to survivors, historians, people of goodwill, and memorials and monuments such as the one in Estonia, to try to tell the truth about the communist system which everywhere ended in misery, costing the lives of 100 million people.

On this background it is extremely concerning and offensive to find Walmart and other retailers promoting what they call “cool shirts“ — bright red tees emblazoned with the Soviet hammer and sickle. Making light of the atrocities committed under and in the name of communism shows ignorance and callousness.

As an Estonian-American living in Europe, I am embarrassed and pained. It is impossible to explain such flippancy to people here, many of whom suffered under communism. People are beginning to think that it is true – Americans care only about making money. I have a hard time convincing them about the America and Americans I know and love, their values and principles, their bravery and willingness to help the downtrodden and oppressed.

Most of my friends here and abroad find this Walmart campaign disgusting. Some have asked, “When will they come out with the companion shirt emblazoned with a swastika?” Precisely this question shows how much still needs to be done to inform and educate people that there were two evil dictators, erstwhile allies, whose crimes and ambitions resulted in so many millions of victims. It is an immense task, but it can be achieved. One place to begin, in this case, is to contact Walmart at all levels. There are many opportunities – their website, their Facebook, your local Walmart store, and management at the highest level.

The executioners killed their victims twice: first by taking their lives and second by erasing the memory of them and their fate. This is why it is important to remember. We cannot undo the first killing, but we can undo the second.

*About the author:*
**Mari-Ann Kelam* served for several years in the Estonian Parliament.

*Source:*
This article was published by the Acton Institute. Reported by Eurasia Review 2 hours ago.

Verona Pharma Announces Publication of Key Paper on RPL554 in COPD in the European Respiratory Journal

September 5, 2018, 11:05 pm

≫ Next: German industrial orders fall unexpectedly in July

≪ Previous: Walmart’s T-Shirt Homage To Mass Murder – OpEd

$

0

0

Publication demonstrates RPL554’s significant bronchodilation effect, in both large and small airways, alone and when combined with currently used bronchodilators in COPD patients

LONDON, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, today announced that the high-impact, peer reviewed European Respiratory Journal has published  a paper entitled “The short term bronchodilator effects of the dual PDE3 and PDE4 inhibitor RPL554 in COPD” that provides full results from two positive Phase 2 clinical studies with RPL554.^* Results from these studies were previously reported by Verona Pharma on May 10, 2016 and September 7, 2017. RPL554 is the Company’s lead first-in-class drug candidate that has a dual bronchodilator and anti-inflammatory mechanism of action. RPL554 has potential as an add-on therapy to improve lung function and reduce symptom severity in chronic obstructive pulmonary disease (COPD) patients whose disease is not being adequately managed by the current standard of care.*Highlights *

Publication details results from two studies demonstrating that RPL554 combined with standard short- and long-acting bronchodilators:

· Causes a pronounced additional bronchodilator effect in both large and small airways.
· Reduces lung hyperinflation, considered a cause of breathlessness in COPD patients.
· Improves speed of onset of action when combined with standard bronchodilators. 

The first study detailed in the publication compared the short-term bronchodilator effects of nebulized RPL554 with that of the commonly used bronchodilators salbutamol (a short-acting beta-agonist) and ipratropium (a short-acting anti-muscarinic agent), as well as placebo, in patients with reversible COPD.  Additional bronchodilator effects when adding RPL554 on top of these agents was also measured.  

The second study detailed the extent of any additional bronchodilation that is achievable, in this patient group, when adding RPL554 to tiotropium (the long-acting anti-muscarinic Spiriva^®, one of the most commonly used drugs to treat COPD). In both studies, peak forced expiratory volume in one second (FEV[1]) lung volumes and specific airway conductance (sGAW) were studied as the principle measures of airway function. In both studies RPL554 demonstrated a placebo like side-effect profile.

The statistically significant results from these studies clearly demonstrate that the bronchodilator effect of RPL554 in patients with reversible COPD is, at the very least, of similar magnitude as that of the commonly used bronchodilators studied, and that clinically meaningful additional bronchodilation could be achieved by adding RPL554 to the treatment of patients with such drugs. The paper concludes that “…RPL554 provided additional bronchodilation, reduced gas trapping, improved airway conductance, and a more rapid onset of action when administered in combination with either a beta-2 agonist or muscarinic antagonist. These short-term bronchodilator studies provide support to further study RPL554 in longer term COPD studies focused on other endpoints including symptoms and exacerbations.”

Jan-Anders Karlsson, PhD, CEO of Verona Pharma, said: “The statistically significant results from the two Phase 2 trials detailed in this important paper continue to highlight the potential and differentiated profile of RPL554 as an add-on therapy to improve lung function and reduce symptom severity in COPD patients whose disease is not being adequately managed by the current standard of care.”

Dave Singh, M.D., Professor of Clinical Pharmacology and Respiratory Medicine, Medicines Evaluation Unit, University of Manchester, and Principal Investigator in these studies, added: “The results published in the European Respiratory Journal not only profile the significant effect of RPL554 on improving lung function in COPD patients when used alone or in combination with commonly used bronchodilators, but also its rapid onset of action, especially when used in combination.”

Verona Pharma is currently conducting a Phase 2 clinical trial to evaluate RPL554 as an add-on treatment to dual LAMA/LABA therapy and triple LAMA/LABA/ICS therapy, as part of a comprehensive clinical program to fully demonstrate the clinical utility of RPL554 in improving the standard of care for COPD. These data will also support the planning of the RPL554 phase 3 program.

*Paper Abstract in Full *

*Introduction*: We investigated the short-term bronchodilator effects of RPL554 (an inhaled dual phosphodiesterase 3 and 4 inhibitor) combined with other bronchodilators in COPD patients with reversibility (>150 mL to short acting bronchodilators).

*Methods*: Study 1: six way placebo controlled crossover study (n=36) with single doses of RPL554 (6mg), salbutamol (200μg), ipratropium (40μg), RPL554 + salbutamol, RPL554 + ipratropium and placebo. Study 2: three way crossover study (n=30) of tiotropium (18 μg) combined with RPL554 (1.5 mg or 6mg) or placebo for 3 days. FEV[1], lung volumes and sGaw were measured.

*Results*: Study 1; Peak FEV[1 ]change compared to placebo was similar with RPL554, ipratropium and salbutamol (means 223, 199 and 187 mL respectively). The peak FEV[1] was higher for RPL554 + ipratropium versus ipratropium (mean difference 94 mL, p
*Conclusion:* RPL554 combined with standard bronchodilators caused additional bronchodilation and hyperinflation reduction.

*About COPD
*Chronic obstructive pulmonary disease (“COPD”) is a progressive and life-threatening respiratory disease for which there is no cure.^1 Although COPD is thought to be underdiagnosed, globally, around 384 million people suffer from the disease.^2 This number, according to the World Health Organization (“WHO”), is likely to increase in coming years, with estimates that COPD will become the third leading cause of death worldwide by 2030.^1,3 The condition damages the airways and the lungs, leading to persistent symptoms of breathlessness, impacting a person’s daily life and their ability to perform simple activities such as walking a short flight of stairs or carrying a suitcase.^1 Many experience acute periods of worsening symptoms called ‘exacerbations’, often leading to emergency department visits or hospital admissions and are also associated with high mortality.^4 In the United States alone, the 2010 total annual medical costs related to COPD were estimated to be $32 billion and are projected to rise to $49 billion in 2020.^5 About 30-40% of moderate to severe COPD patients on triple inhaled therapy (ICS/LAMA/LABA) remain uncontrolled and continue to experience airway obstruction (breathing difficulties), COPD symptoms and exacerbations.^6 There is an urgent need for drugs with novel mechanisms of action that can be used by these patients in addition to current therapies.

_______________

^* Singh D et al; Eur Respir J. *2018* Aug 30. pii: 1801074. https://doi.org/10.1183/13993003.01074-2018

*About Verona Pharma plc and RPL554*
Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. Verona Pharma’s product candidate, RPL554, is a first-in-class, inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. In previous clinical trials, RPL554 has been observed to result in bronchodilator effects when used alone or as an add-on treatment to other COPD bronchodilators. It has shown clinically meaningful and statistically significant improvements in lung function when administered in addition to frequently used short- and long-acting bronchodilators, such as tiotropium (Spiriva®), compared with such bronchodilators administered as a single agent. RPL554 improved FEV[1] over four weeks in patients with moderate-to-severe COPD when compared to placebo and improved COPD symptoms and Quality of Life in a Phase 2b multicenter European study performed in 403 patients. In addition, RPL554 has shown anti-inflammatory effects in a standard challenge study with COPD-like inflammation in human subjects. RPL554 has been well tolerated in these studies and has a favorable safety and tolerability profile, having been administered to more than 730 subjects in 12 clinical trials. Verona Pharma is developing RPL554 for the treatment of chronic obstructive pulmonary disease (“COPD”), cystic fibrosis (“CF”), and potentially asthma.

*Forward-Looking Statements*
This press release contains forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding the design of the Phase 2 clinical trial of RPL554, the timing of availability of top-line data for the Phase 2 clinical trial, the importance of the Phase 2 clinical trial to our development plans for RPL554, the potential of RPL554 as a promising first-in-class treatment option for COPD, and the value of the data and insights that may be gathered from the Phase 2 clinical trial, including for the purpose of designing pivotal Phase 3 trials.

These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from our expectations expressed or implied by the forward-looking statements, including, but not limited to, the following: our limited operating history; our need for additional funding to complete development and commercialization of RPL554, which may not be available and which may force us to delay, reduce or eliminate our development or commercialization efforts; the reliance of our business on the success of RPL554, our only product candidate under development; economic, political, regulatory and other risks involved with international operations; the lengthy and expensive process of clinical drug development, which has an uncertain outcome; serious adverse, undesirable or unacceptable side effects associated with RPL554, which could adversely affect our ability to develop or commercialize RPL554; potential delays in enrolling patients, which could adversely affect our research and development efforts and the completion of our Phase 2 trial; we may not be successful in developing RPL554 for multiple indications; our ability to obtain regulatory approvals necessary to conduct later stage trials and to commercialize RPL554 in multiple major pharmaceutical markets; misconduct or other improper activities by our employees, consultants, principal investigators, and third-party service providers; material differences between our “top-line” data and final data; our reliance on third parties, including clinical investigators, manufacturers and suppliers, and the risks related to these parties’ ability to successfully develop and commercialize RPL554; and lawsuits related to patents covering RPL554 and the potential for our patents to be found invalid or unenforceable. These and other important factors under the caption “Risk Factors” in our Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on February 27, 2018 relating to our Registration Statement on Form F-1, and our other reports filed with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

*For further information, please contact:*

   
Verona Pharma plc Tel: +44 (0)20 3283 4200
Jan-Anders Karlsson, Chief Executive Officer info@veronapharma.com 
   
Stifel Nicolaus Europe Limited (Nominated Adviser
and UK Broker) Tel: +44 (0) 20 7710 7600
Stewart Wallace / Jonathan Senior / Ben Maddison  
   
FTI Consulting (UK Media and Investor enquiries) Tel: +44 (0)20 3727 1000
Simon Conway / Natalie Garland-Collins veronapharma@fticonsulting.com 
   
ICR, Inc. (US Media and Investor enquiries)  
James Heins Tel: +1 203-682-8251
James.Heins@icrinc.com
Stephanie Carrington Tel. +1 646-277-1282
Stephanie.Carrington@icrinc.com 
   

^1World Health Organization. Chronic Obstructive Pulmonary Disease. http://www.who.int/mediacentre/factsheets/fs315/en/. Accessed September 2017.
^2 Adeloye D, Chua S, et al. Global and regional estimates of COPD prevalence: Systematic review and meta–analysis. J Glob Health2015; 5(2): 020415.
^3World Health Organization. Burden of COPD. http://www.who.int/respiratory/copd/burden/en/. Accessed September 2017.
^4 COPD Foundations. Characteristics of COPD Patients Using United States Emergency Care or Hospitalization. https://journal.copdfoundation.org/jcopdf/id/1103/Characteristics-of-COPD-Patients-Using-United-States-Emergency-Care-or-Hospitalization. Accessed September 2017.
^5Center for Disease Control. Increase Expected in Medical Costs for COPD. https://www.cdc.gov/features/ds-copd-costs/. Accessed September 2017.
^6 Mullerova H., et al., Characterization of COPD Patients Treated With Inhaled Triple Therapy Containing Inhaled Corticosteroid [ICS], Long-Acting Beta2-Agonists [LABA], and Long-Acting Muscarinic Antagonists [LAMA] in the UK, American Journal of Respiratory and Critical Care Medicine 2017;195:A4986
^6 Vestbo J, et al., Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINTY); a double-blind, parallel group, randomised controlled trial, The Lancet, Vol 389, p. 1919-1929; May 13, 2017. Reported by GlobeNewswire 2 hours ago.

German industrial orders fall unexpectedly in July

September 5, 2018, 11:31 pm

≫ Next: TECH Europe relocation plan endangers 53 jobs in Northern Ireland

≪ Previous: Verona Pharma Announces Publication of Key Paper on RPL554 in COPD in the European Respiratory Journal

$

0

0

German industrial orders fell unexpectedly in July after plunging in the previous month, data showed on Thursday, in a further sign that factories in Europe's largest economy are feeling the bite of protectionist trade policies. Reported by Reuters India 1 hour ago.

TECH Europe relocation plan endangers 53 jobs in Northern Ireland

September 5, 2018, 11:49 pm

≫ Next: Global EMI Shielding Market Expected to Reach USD 7.95 Billion by 2024: Zion Market Research

≪ Previous: German industrial orders fall unexpectedly in July

$

0

0

Around 50 jobs at a tyre repair materials plant in Lisburn are at risk after the US-owned company launched a major review of its business. Reported by Belfast Telegraph 59 minutes ago.

Global EMI Shielding Market Expected to Reach USD 7.95 Billion by 2024: Zion Market Research

September 5, 2018, 11:25 pm

≫ Next: Stonewall Resources strengthens balance sheet and appoints new chairman

≪ Previous: TECH Europe relocation plan endangers 53 jobs in Northern Ireland

$

0

0

According to the report, global EMI shielding market was valued at USD 5.46 billion in 2017, is expected to reach USD 7.95 billion in 2024 and is anticipated to grow at a CAGR of 5.5% between 2018 and 2024.

New York, NY, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled *“EMI Shielding Market by Component (EMI Shielding Tapes & Laminates, Conductive Coatings & Paints, Metal Shielding, Conductive Polymers, and EMI/EMC Filters), by Method (Radiation and Conduction), and by End-use Industry (Consumer Electronics, Telecom & IT, Automotive, Healthcare, Defense & Aerospace, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024”*. According to the report, global EMI shielding market was valued at USD 5.46 billion in 2017, is expected to reach USD 7.95 billion in 2024 and is anticipated to grow at a CAGR of 5.5% between 2018 and 2024. 

EMI shielding protects electronic devices from corrosion and oxidation. It is widely used in several end-use industries such as telecom & IT, automotive, healthcare, consumer electronics, and other industries. Increasing technological advancements in EMI shielding is widely utilized in the aerospace industry. Further, growing demand for consumer electronics such as smartphones, tablets, portable communication devices, LED, and LCD coupled with changing lifestyle is expected to boost the demand for EMI shielding across the globe. EMI shielding is used in consumer electronics due to the improved radiation shielding of circuits and chips of medical devices and this is projected to fuel the market growth in the forecast period.

*Browse through 54 Tables & 43 Figures spread over 110 Pages and in-depth TOC on “Global EMI Shielding Market: Materials, Industry Size, Share, Analysis and Forecast, 2017 - 2024”.*

*Request Free Sample Report of Global EMI Shielding Market Report @* https://www.zionmarketresearch.com/sample/emi-shielding-market

The global EMI shielding market can be segmented based on component, method, end-use industry, and regions. Based on the component, the global EMI shielding market is segregated into EMI shielding tapes & laminates, metal shielding, conductive polymers, conductive coatings & paints, and EMI/EMC filters. Conductive coatings & paints are expected to grow at the fastest pace in the upcoming years. It is due to its thermal properties and easy application on nylon and plastic resins such as polyphenylene oxide (PPO), polyphthalamide (PPA), polycarbonate, polybutylene terephthalate (PBT), and polystyrene (PS). Therefore, it is used in a wide range of devices such as smartphones and tablets. The global EMI shielding market is segmented into methods which include radiation and conduction. However, radiated EMI shielding is widely used in electronic devices and has the potential to enhance its application in several end-use industries. On the basis of end-user industry, the market is classified as consumer electronics, telecom & IT, defense & aerospace, healthcare, automotive, and others. Consumer electronics is anticipated to witness significant gains in the forecast period. In addition, increasing demand from the automotive industry is projected to propel the EMI shielding market growth in the forecast period.  

*Download Free Report Brochure: *https://www.zionmarketresearch.com/requestbrochure/emi-shielding-market

North America and Europe are the highest growing regional market for EMI shielding and is expected to witness significant growth in the upcoming years. North America is anticipated to grow substantially owing to the increasing demand from the aerospace & defense industry. North America accounted for about 25% of the market share in 2016 owing to the increased demand for LEDs in the region. Moreover, EMI shielding increases the efficiency of operations and provides enhanced safety and therefore, it is widely used in the aerospace industry. Rising healthcare industry amongst the region is projected to increase the demand for EMI shielding in various purposes, thereby, fueling the EMI shielding market. Europe EMI shielding market is projected to grow at the fastest pace owing to the increasing demand from the automotive industry. Additionally, the technological advancement and significant investment in the electronics industry is estimated to drive the EMI shielding market in the region. However, the high cost of EMI shielding is anticipated to hinder the market in the future. But, opportunities arising from 5G technology are estimated to propel the EMI shielding market in the upcoming years.  

Latin America is anticipated to show moderate growth in the forecast period. Growing automotive industry in the region is likely to increase the demand for EMI shielding in the region. Moreover, increasing demand for consumer electronics across the region is expected to enhance the demand for EMI shielding market. 

Browse the full *"EMI Shielding Market by Component (EMI Shielding Tapes & Laminates, Conductive Coatings & Paints, Metal Shielding, Conductive Polymers, and EMI/EMC Filters), by Method (Radiation and Conduction), and by End-use Industry (Consumer Electronics, Telecom & IT, Automotive, Healthcare, Defense & Aerospace, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024"* report at https://www.zionmarketresearch.com/report/emi-shielding-market

In the Middle East & Africa, rising industrialization is projected to register decent market growth for EMI shielding in the coming years. In addition, increasing demand from the healthcare industry is anticipated to spur the EMI shielding market. Growing population has led to increased usage of electronic gadgets such as tablets, smartphones, and others which, in turn, is expected to propel the EMI shielding market in the region.

The EMI shielding market consists of a large number of players and is highly divided. Companies operating in this market include Chomerics, RTP Company, 3M Company, Tech-Etch Inc., ETS-Lindgren, Laird Plc., Schaffner Holding AG, Henkel AG & Co. KGaA, PPG Industries Inc., Kitagawa Industries Co., Ltd., and Leader Tech Inc., among others. 

*Inquire more about this report before purchase @ *https://www.zionmarketresearch.com/inquiry/emi-shielding-market

*The report segments the global EMI shielding market as:*

*Global EMI Shielding Market: Component Analysis*

· EMI Shielding Tapes & Laminates
· Conductive Coatings & Paints
· Metal Shielding
· Conductive Polymers
· EMI/EMC Filters

*Global EMI Shielding Market: Method Analysis*

· Radiation
· Conduction

*Global EMI Shielding Market: End-Use Industry Analysis*

· Consumer Electronics
· Telecom & IT
· Automotive
· Healthcare
· Defense & Aerospace
· Others

*Global EMI Shielding Market: Regional Analysis*

· North America

· The U.S.

· Europe

· UK
· France
· Germany

· Asia Pacific

· China
· Japan
· India

· Latin America

· Brazil

· The Middle East and Africa

*Browse More Related Category Reports:*

· *Concrete Admixture Market:* https://www.zionmarketresearch.com/report/concrete-admixtures-market
· *Benzoic Acid Market:* https://www.zionmarketresearch.com/report/benzoic-acid-market
· *Epoxy Curing Agents Market:* https://www.zionmarketresearch.com/report/epoxy-curing-agents-market
· *Water Testing and Analysis Market:* https://www.zionmarketresearch.com/report/water-testing-and-analysis-market
· *Silicone Elastomers Market:* https://www.zionmarketresearch.com/report/silicone-elastomers-market

*About Us:*Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

*Follow Us LinkedIn: *https://www.linkedin.com/company/zion-market-research
*Follow Us Twitter: *https://twitter.com/zion_research

*Blog:* http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com

*Contact Us:*

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
*Email:* sales@zionmarketresearch.com

*Website:* https://www.zionmarketresearch.com

*Blog:* http://zmrblog.com Reported by GlobeNewswire 1 hour ago.

Stonewall Resources strengthens balance sheet and appoints new chairman

September 6, 2018, 12:34 am

≫ Next: USD/CHF looks to extend the recovery above 0.9700

≪ Previous: Global EMI Shielding Market Expected to Reach USD 7.95 Billion by 2024: Zion Market Research

$

0

0

Stonewall Resources Ltd (ASX:SWJ) has appointed Bill Guy, who was first appointed to the board as a director in March this year, as chairman of the board. Guy is a professional geologist with over 25 years’ experience in exploration and resource development in Asia, Australia, and Europe. His appointment is part of Stonewall’s strategy to develop a strong technical board. Guy’s most recent appointment was as managing director of Longford Resources Ltd (ASX:LFR). READ: Stonewall Resources closes in on updated resource at Theta Hill Stonewall’s chairman Bill Guy said: “Stonewall’s exploration ground position and current resource base are unique for a junior explorer. “I was attracted by the geology and the scalability of the project. The multiple flat lying high-grade gold seams offer excellent drill targets. “The lack of modern exploration in goldfields this size would simply not happen in Australia. “Stonewall is at the beginning of exploring a long life asset with numerous historical mines untested by drilling.” Stonewall gets rid of more debt from its balance sheet Stonewall has also retired $4.6 million of debt in the past 12 month, which is part of the company’s balance sheet repair strategy. The debt was in the form of a convertible note held by Tasman Funds Management, who elected to convert the note to shares. Stonewall issue 251.4 million shares to settle the note, which are subject to voluntarily escrow for 12 months through to 4 September 2019. Guy added: “I am pleased to inform shareholders that the Tasman convertible note retired this week, significantly strengthening the company’s financial position.” Reported by Proactive Investors 15 minutes ago.

USD/CHF looks to extend the recovery above 0.9700

September 5, 2018, 11:39 pm

≫ Next: Nexcess Brings Dev Sites to WordPress and WooCommerce Cloud Hosting

≪ Previous: Stonewall Resources strengthens balance sheet and appoints new chairman

$

0

0

· *Swiss economy expands +0.7% q/q in Q2 versus +0.5% expected.*
· *Recovers in sync with US dollar ahead of tariffs deadline and US data.*

The USD/CHF pair is seen trying hard to extend its Asian recovery into Europe, as the Swiss Franc derives support from a solid Swiss Q2 GDP report. The Swiss GDP rate grew by 0.7% q/q and 3.4% y/y in the second quarter of 2018, the latest data from State Secretariat for Economic Affairs showed.

The spot bounced from the Asian session lows of 0.9695, tracking the recovery in the US dollar across its main competitors, as markets flocked to the US currency in search of safety ahead of the looming US tariffs deadline, as the public hearing for the US' $200 billion tariffs concludes today.

Looking ahead, the pair will continue to get influenced by the US dollar dynamics, as markets await the US ADP jobs data and ISM non-manufacturing PMI report for fresh trading impetus.

*USD/CHF Technical Levels*

Higher side levels: 0.9720 (10-DMA), 0.9749 (200-DMA), 0.9800 (round number).

Lower-side levels: 0.9695 (daily low), 0.9652 (Aug 30 low), 0.9600 (key support).** Reported by FXstreet.com 1 hour ago.

---

Nexcess Brings Dev Sites to WordPress and WooCommerce Cloud Hosting

September 6, 2018, 12:05 am

≫ Next: Discover the Latest Opportunities in Hotel Investment in Israel at IHIS 2018

≪ Previous: USD/CHF looks to extend the recovery above 0.9700

$

0

0

Nexcess has announced the introduction of Cloud Dev Sites to the Nexcess Cloud. The new Dev Sites allow WordPress and WooCommerce cloud hosting clients to instantly deploy secure development and staging sites on the Nexcess Cloud platform.

SOUTHFIELD, Mich. (PRWEB) September 06, 2018

Nexcess has announced the introduction of Cloud Dev Sites to the Nexcess Cloud. The new Dev Sites allow WordPress and WooCommerce cloud hosting clients to instantly deploy secure development and staging sites on the Nexcess Cloud platform.

Development sites are used to develop and test code and design changes that could affect the performance and stability of a production site. A Nexcess Cloud Dev Site is a complete copy of a production WordPress site or WooCommerce store, with the same software versions, scrubbed data, and identical cloud infrastructure.

“The Nexcess Cloud was built with developers in mind. From release, we offered version control integration with support for Git, multi-user SSH access, and Composer support,” commented Chris Wells, President and CEO of Nexcess. “The addition of secure development and staging sites makes it even easier for Nexcess clients to iterate quickly and safely on their websites and eCommerce stores.”

Nexcess Cloud Dev Sites provide a secure environment for development and testing. All personally identifying data in the production database is replaced with placeholder information and unique encryption keys are used in each development site. This data scrubbing process means that Nexcess Cloud Dev Sites can be worked on by third-party agencies, developers, and testers without exposing sensitive data.

The Nexcess Cloud provides flexible, scalable hosting for WordPress, WooCommerce, Magento, and CraftCMS sites of any size. Nexcess cloud users benefit from instant self-service upgrades and downgrades, and automatic scaling that dynamically increases resources to ensure that sites and eCommerce stores always have the resources they need.

In the Nexcess Cloud, each hosting environment is optimized to maximize the performance and stability of the application it hosts, including PHP, database, caching, operating system, and network optimizations.

About Nexcess

Nexcess is a Southfield, Michigan-based managed application hosting company founded in 2000, with data centers distributed throughout the United States, Europe, and Australia. Nexcess offers a variety of managed hosting services for Magento, WordPress, WooCommerce, ExpressionEngine, and Craft CMS that includes entry-level shared hosting, scalable cloud hosting, and custom clustered/complex hosting configurations, with an emphasis on achieving maximum performance for high-traffic sites. For more information, visit http://www.nexcess.net. Reported by PRWeb 44 minutes ago.

Discover the Latest Opportunities in Hotel Investment in Israel at IHIS 2018

September 6, 2018, 12:01 am

≫ Next: 'K11 ARTUS' Luxury Hotel Residences to open in summer 2019 at Victoria Dockside District

≪ Previous: Nexcess Brings Dev Sites to WordPress and WooCommerce Cloud Hosting

$

0

0

Discover IHIS 2018. IHIS provides you with an excellent opportunity to join a wealth of world-leading developers, investors, operators and strategists as they explore the opportunities within Israels hotel market.

LONDON (PRWEB) September 06, 2018

With only 11 weeks to go until the inaugural Israel Hotel Investment Summit 2018 take place in Tel Aviv book your ticket now to discover the latest opportunities in Israel. Questex Hospitality Group are delighted to announce the inaugural Israel Hotel Investment Summit (IHIS), co-organised with The Israel Ministry of Tourism will be held on 19-20 November 2018 at The Hilton Hotel, Tel Aviv. The summit will provide senior hospitality and tourism leaders with the opportunity to gain extensive insight into the tourism and development opportunities available in Israel.

WHY ISRAEL?
2018 could not be a better time for domestic and international hotel investors and operators to discover the opportunities for expanding their interests in Israel. A country drenched in history, Israel offers visitors the opportunity to experience a rich and vibrant culture from historical landmarks to unique cuisine - all interests and tastes are catered for. With the Israel Airport Advisory confirming the introduction of 25 new routes flying in and out of Israel in 2017 and current demand outstripping supply and a wealth of opportunities there has never been a better time to invest in Israel.

IHIS provides you with an excellent opportunity to join a wealth of world-leading developers, investors, operators and strategists as they explore the opportunities within Israel. The two-day summit will provide focused content from global experts on investment opportunities, funding strategies and market specific requirements allowing attendees to get a true feel for the market. In addition to the conference the summit will also provide specialised networking opportunities throughout the event and a series of site visits to the Old City of Jerusalem, The Setai – Tel Aviv and The Orient Hotel – Tel Aviv.

AUDIENCE BREAKDOWN
Who you will meet at IHIS by %
34% - Investors, Asset Managers, Financial Advisors, Private Equity & Lenders
30% - Hotel Brands
10% - Developers
9% - Real Estate Agents & Surveyors
7% - Architects & Designers
5% - Media
5% - Other

FAST FACTS
Tourism interest in Israel continues to grow, and the numbers are here to prove it:
2017· Israel reached an all-time record of 3.6 million visitors (up 25% from 2016)
· 25 new airline routes introduced in 2017

2018· Over 4 million visitors expected
· Estimated to bring in NIS 20 billion/USD 5.5 billion in revenue

"Israel is increasingly becoming an attraction for international hoteliers, operators, investors and developers, as the country’s growth in visitation, both from overseas and from within, continues to set new records. Tel Aviv in particular has become a magnet for those seeking new experiences and is one of the ‘hot’ destinations in the world. With 3,000 years of history and a year-round climate, Israel has also become a ‘hot’ destination for hotel investment. IHIS will enable the spotlight to be shone on the opportunities which are now available in Israel and at the same time provide an important forum to help them come to fruition." Russell Kett, Chairman, HVS

To join us for the inaugural Israel Hotel Investment Summit (IHIS), co-organised with The Israel Ministry of Tourism on 19-20 November 2018 at The Hilton Hotel Tel Aviv please book below.

BOOK YOUR ATTENDANCE HERE

PRESENTATION HIGHLIGHTS

Tuesday 20 November 2018

11.30 – 12.30: Panel Session: Investment: Where are the deals and who is investing?
Moderator: Russell Kett – Chairman, HVS London
Panel: Jonathan Falik – CEO, JF Capital Advisors | Michael Karmon - Investment Banker, International Property Investments, Cukierman | Neil Kaye – CEO, Silverock Investments
Operational Panel: What are the Optimal Models for Running Hotels Successfully in Israel?

3:15pm - 4:00pm: Moderator: Ronit Copeland – MD, Copeland Hospitality
Panel: Alex Delaroff – COO, AccorHotels, Israel | Michael Hay – Founder and Managing Partner, Vision Hospitality | David Jenkins – Vice President, Development, Russia, CIS, Baltics & Israel, Radisson Hotel Group | Alan Mantin – Managing Director Development, Southern Europe, Hilton

18.00 – 18.30: Closing Keynote: Hospitality at the crossroads of culture and innovation
Uri Jeremias, Chef and Proprietor – Uri Buri Restaurant and Efendi Hotel

ACCESS THE FULL PROGRAMME HERE

-ENDS- Reported by PRWeb 47 minutes ago.

'K11 ARTUS' Luxury Hotel Residences to open in summer 2019 at Victoria Dockside District

September 6, 2018, 12:05 am

≫ Next: GridGain® Experts Host, Attend Industry Events to Help Businesses Harness the Power of In-Memory Computing

≪ Previous: Discover the Latest Opportunities in Hotel Investment in Israel at IHIS 2018

$

0

0

HONG KONG, Sept. 6, 2018 /PRNewswire/ -- New World Development, one of Asia's most celebrated developers, announces today its art and design district Victoria Dockside will feature a new luxury hotel residence concept. Located at the Tsim Sha Tsui waterfront, the residences, named* K11 ARTUS*, are scheduled to open in summer 2019.

 

 K11 ARTUS - luxury hotel residences within the art and design district Victoria Dockside

 K11 ARTUS hotel residences overlook the iconic harbourfront of Victoria Harbour

Comprising 287 residences and spanning across 14 storeys, *ARTUS* is an extension of the K11 brand, the global high-end lifestyle brand that embraces Art, People and Nature. Capturing these three core attributes of the K11 brand, the *ARTUS* name is a portmanteau combining the English word "Art" with the Latin term "Domus", meaning 'home.' Within these individual residences, guests are presented with an inspiring environment to curate their own lifestyle and craft their own experiences.

A port for creatives and intellectuals to gather, *ARTUS* is designed for worldly travellers who champion authenticity, appreciate personalisation and celebrate luxury. With eclectic touches and customised elements, each suite will be a private residence to inspire quiet contemplation and a personal connection.

"*ARTUS* marks a major milestone for the K11 brand with our expansion into the hospitality sector," said Mr. Adrian Cheng, K11 Founder, Executive Vice-Chairman of New World Development. "Our intention is to reshape the serviced apartment experience by designing private residences that encourage discerning visitors to reflect on profound ideas and pursue their creative passions. More than a place to live, *ARTUS* will be a welcoming space for intelligent minds to find inspiration."

A testament to creativity and collaboration,* ARTUS* reflects the combined talents of Asia's most celebrated designers and international architectural firms. Kohn Pedersen Fox, the award-winning New York-based architectural studio, designed the building while Bangkok-based P Landscape (PLA) is responsible for the surrounding greenery that will form an integral part of the guest journey.

Hong Kong-based globally acclaimed architect Andre Fu and his studio AFSO have been engaged to create the interiors. In designing ARTUS, Andre Fu drew inspirations from the spirit of historical venues where like-minded individuals gathered. Transversal in different cultures, these venues encourage critical thinking and the sharing of ideas. Building on this narrative, Andre imagined the interiors as a contemporary artist's residence that rejuvenates and inspires creative minds. Guests will be invited to immerse themselves in a world of bespoke vintage-inspired furnishings, handcrafted details and whimsical twists.

"*ARTUS* will distinguish itself from the corporate, mainstream concept of most serviced apartments, and set a new paradigm for the industry," said Paul Cunningham, General Manager of Hospitality and Portfolio Management of New World Development. "The residences demonstrate craftsmanship, bespoke experiences, attention to detail, and present unparalleled views of the Victoria Harbour. Combining the convenience of hotels and the comfort of serviced apartments, *ARTUS* offers flexible rental plans from short- to long-term stays to accommodate the needs of our guests."

Boasting the open-air waterfront views of Victoria Harbour and Hong Kong Island, *ARTUS* will be part of the groundbreaking Victoria Dockside development, the 3 million-square-foot art and design district in Tsim Sha Tsui. Described by US media as "Hong Kong's Hudson Yards" and "Hong Kong's most anticipated opening," this US$2.6 billion development includes the K11 Atelier office tower and K11 MUSEA, a new ultra-high-end experiential retail, art, cultural and dining destination.

To learn more about K11 ARTUS and its inspirations, please click: http://www.artus.com.hk/concept

*Notes to Editors: *

*About K11 Group*

Founded in 2008 by entrepreneur Adrian Cheng, K11 Group combines art and commerce in commercial and residential real estate, and a growing portfolio of brands across different sectors in Greater China and around the world. Marking its 10th anniversary, K11 Group announced its most ambitious museum-retail development K11 MUSEA in June 2018, situated at the heart of the new $2.6bn Victoria Dockside art and design district developed by parent company New World Group in Hong Kong, scheduled to fully open in 2019. In addition to its flagship K11 Art Malls, K11 Group also operates K11 Atelier, a network of office buildings for the next-generation workforce; luxury hotel residences for worldly travellers K11 ARTUS; open education platform K11 Kulture Academy; the terrarium-inspired transformative retail concept K11 Natural; consulting and market research institution K11 Chinese Millennials Taskforce; and K11 Art Foundation, China's first not-for-profit to incubate Chinese artists and curators.

K11 Group is based in Hong Kong and has operations in Greater China, as well as investments in Europe and the US.

Through K11 Group, Cheng's stated aim is to constantly innovate and "connect China's cultural ecosystem and its emerging millennials and Generation Z with the world", creating a new global identity for Chinese millennials. By 2023 K11 Group will have gained a footprint in nine cities across Greater China.

*New World Development Company Limited*

Founded in 1970, New World Development Company Limited ("the Group", Hong Kong stock code: 0017) was publicly listed in Hong Kong in 1972 and is a constituent stock of the Hong Kong Hang Seng Index. A premium brand infused with a unique personality defined by The Artisanal Movement, New World Group's core business areas include property development, property investment, infrastructure and services, department stores and hotels. As at 31 December 2017, the total asset value of the Group amounted to HK$468.1 billion. The Group has an effective interest of approximately 61% in NWS Holdings Limited (Hong Kong stock code: 0659), approximately 75% in New World Department Store China Limited (Hong Kong stock code: 0825) and wholly owned New World China Land Limited.

Video - https://cdn4.prnasia.com/002071/mnr/video/20180905K11ARTUS.mp4
Photo - https://photos.prnasia.com/prnh/20180905/2228758-1-a
Photo - https://photos.prnasia.com/prnh/20180905/2228758-1-b
Logo - https://photos.prnasia.com/prnh/20180905/2228758-1LOGO

Related Links :

http://www.artus.com.hk Reported by PR Newswire Asia 43 minutes ago.

GridGain® Experts Host, Attend Industry Events to Help Businesses Harness the Power of In-Memory Computing

September 6, 2018, 12:04 am

≫ Next: Groupama Asset Management Automates its Front and Middle Office Operations with SimCorp Dimension

≪ Previous: 'K11 ARTUS' Luxury Hotel Residences to open in summer 2019 at Victoria Dockside District

$

0

0

FOSTER CITY, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- GridGain® Systems, provider of enterprise-grade in-memory computing solutions based on Apache® Ignite™, today announced 25 webinars, conferences and meetups where GridGain experts will be speaking during September and October of 2018. Topics include sharing insights and strategies for how businesses of all sizes can meet the real-time performance and massive scalability requirements of data-intensive applications being developed for digital transformation and omnichannel customer experience initiatives.“To succeed at digital transformation, organizations must solve the real-time speed and massive scalability challenges of their applications,” said Terry Erisman, Vice President of Marketing at GridGain. “Whether it’s at our In-Memory Community Summit North America or a more intimate industry meet-up, our experts are committed to helping companies understand which in-memory computing solution works best for their particular use cases and how to optimize their deployments. I strongly recommend that anyone interested in in-memory computing attend one of these excellent events.”

During September and October, GridGain will host or participate in the following conferences, webinars and meetups:

In Memory Computing Summit

· *In-Memory Computing Summit North America 2018* – October 2-3, 2018 – GridGain Systems will host the only industry-wide event in North America focused on the full range of in-memory computing-related technologies and solutions. Attendees will learn about the role of in-memory computing in the digital transformation of enterprises. Held in Silicon Valley, the conference is attended by technical decision makers, business decision makers, architects, CTOs, developers and more who make or influence purchasing decisions about in-memory computing, Big Data, Fast Data, IoT, and HPC solutions.

Conferences & Webinars

· *Strata New York 2018* – September 11-13, 2018 – GridGain will be in booth #1101 to discuss the needs for in-memory computing solutions for real-time big data applications.
· *GridGain Webinar: Best Practices for Stream Ingestion, Processing and Analytics Using In-Memory Computing *– September 12, 2018 – GridGain Director of Product Management and Vice President of Apache Ignite PMC Denis Magda will provide best practices used for real-time stream ingestion, processing and analytics using Apache® Ignite™, GridGain®, Apache Kafka™, Apache Spark™ and other technologies.
· *GridGain Webinar: Managing and Monitoring Apache Ignite and GridGain* –
· September 19, 2018 – Andrey Evsukov, Head of Operations at GridGain Systems, will provide best practices for how to monitor and manage a production Apache® Ignite™ or GridGain® cluster. The webinar will show how to benefit from JMX metrics, demonstrate how to use the Web Console – an interactive management tool and configuration wizard for Apache Ignite and GridGain – and include a discussion of third-party tools that also address management and monitoring needs.
· *GridGain Webinar: Apache Ignite + GridGain: Powering Up Banks and Financial Institutions with Distributed Systems* – September 25, 2018 – GridGain Technology Evangelist Akmal Chaudhri will provide an overview of Apache Ignite and the GridGain in-memory computing platform, which is built on Apache Ignite, and discuss the key capabilities and features for financial applications, including ACID compliance, ANSI-99 SQL support, persistence, replication, security, fault tolerance, fraud detection and more.
· *Oracle Code One Conference 2018* – October 22-25, 2018 – GridGain will be on the expo floor to discuss the needs and options for in-memory computing solutions for real-time big data applications.

Meetups

· *Data Natives European Tour *– GridGain Technology Evangelist Akmal Chaudhri will present “How to become a Big Data Rockstar in 15 minutes!" in several European cities throughout September:

· *Copenhagen* – September 4, 2018
· *Hamburg* – September 5, 2018
· *Berlin* – September 6, 2018
· *Frankfurt* – September 10, 2018
· *Vienna* – September 11, 2018
· *Munich* – September 12, 2018
· *Zurich* – September 13, 2018
· *Paris* – September 17, 2018
· *Amsterdam* – September 18, 2018
· *London* – September 19, 2018

· *Apache Ignite Meetup Moscow #4* – September 11, 2018 – Artem Schitow, Solutions Architect at GridGain Systems, will present “What's new in Apache Ignite 2.7.” The meet-up will also feature a talk by Nikolai Izhikov of Sberbank Technologies on “Ignite + Spark Data Frame. Together ever after.”
· *Metis New York Data Science Meetup* – September 12, 2018 – Denis Magda, Director of Product Management at GridGain Systems and Vice President of the Apache Ignite PMC, will preside over a two-hour workshop titled, "In-Memory Computing Essentials for Data Scientists."
· *Open Source Summit Japan 2018* – September 21, 2018 – Roman Shtykh with Yahoo! Japan will present “Apache Ignite: From In-Memory Data Grid to Memory-Centric Distributed Database."
· *Big Data Meetups* – GridGain Technology Evangelist Akmal Chaudhri will also present his talk “How to become a Big Data Rockstar in 15 minutes!" at several Big Data Meetups across Europe:

· *Big Data, Oslo V 3.0 Meetup* – September 27, 2018
· *Big Data, Helsinki V 2.0 Meetup* – October 4, 2018
· *Big Data, Singapore V 2.0 Meetup* – October 8, 2018
· *Big Data, Stockholm V 6.0 Meetup* – October 11, 2018
· *Big Data, Brussels V 3.0 Meetup* – October 17, 2018
· *Big Data, Luxembourg V 3.0 Meetup* – October 18, 2018

· *Future of Data: New York Meetup* – October 24, 2018 – GridGain Technology Evangelist Akmal Chaudhri will be a featured speaker and present "Best Practices for Stream Ingestion, Processing and Analytics Using In-Memory Computing." 

*About GridGain® Systems*
GridGain Systems is revolutionizing real-time data access and processing by offering an in-memory computing platform built on Apache® Ignite™. GridGain solutions are used by global enterprises in financial, software, e-commerce, retail, online business services, healthcare, telecom and other major sectors, with a client list that includes ING, Sberbank, Finastra, IHS Markit, Workday, and Huawei. GridGain delivers unprecedented speed and massive scalability to both legacy and greenfield applications. Deployed on a distributed cluster of commodity servers, GridGain software can reside between the application and data layers (RDBMS, NoSQL and Apache® Hadoop®), requiring no rip-and-replace of the existing databases, or it can be deployed as an in-memory transactional SQL database. GridGain is the most comprehensive in-memory computing platform for high-volume ACID transactions, real-time analytics, web-scale applications, continuous learning and HTAP. For more information, visit* gridgain.com*.

*CONTACT:*
Terry Erisman
GridGain Systems
terisman@gridgain.com
(650) 241-2281

GridGain is a trademark or registered trademark of GridGain Systems, Inc. Apache, Apache Hadoop, Hadoop, Apache Ignite, Ignite, Apache Kafka, Kafka, Apache Spark, and Spark, are trademarks of The Apache Software Foundation. All other product and company names herein may be trademarks of their registered owners. Reported by GlobeNewswire 44 minutes ago.

Groupama Asset Management Automates its Front and Middle Office Operations with SimCorp Dimension

September 6, 2018, 12:04 am

≫ Next: $21.7 Million Sports Bras Market - Global Shares, Market Strategies, and Market Forecasts, 2018-2024

≪ Previous: GridGain® Experts Host, Attend Industry Events to Help Businesses Harness the Power of In-Memory Computing

$

0

0

Press Release

SimCorp, a leading provider of investment management solutions and services to the global financial services industry, today announced that Groupama Asset Management has gone live with the deployment of SimCorp Dimension, to automate its front and middle office operations. Groupama Asset Management, a subsidiary of the Groupama insurance group has grown to become one of France’s largest asset managers, with more than EUR 100bn in assets under management. Its addition to the SimCorp community sees it joining some of the leading insurers around the world who are moving into the asset management space to reap diversified returns, aided by a cost-effective, multi-asset class IT infrastructure. 

To scale for growth, Groupama Asset Management decided to consolidate and simplify its IT throughout its front and middle office operations, to increase efficiency, gain agility and reduce operational risk. The group required a flexible and integrated solution enabling them to enhance the management of assets & liabilities, onboard complex instruments in line with the latest regulations, and deliver new and advanced functionality. After a rigorous selection process, SimCorp Dimension stood out as the solution that best addressed Groupama Asset Management’s current criteria, above and beyond the initial project scope, as well as offering the ability to scale for the future.

*Hubert Le Lourd**, Chief Operating Officer at **Groupama Asset Management,* commented: “The implementation of SimCorp Dimension enables us to both focus on our core business and to position ourselves for further expansion. Having gone live, we’ve already seen major benefits, including the removal of more than 10 solutions, much broader front and middle office functionality and most importantly, access to real-time data that enables our front office to make more timely and informed investment decisions. The collaboration between Groupama AM and SimCorp has been key in the timely delivery of this project.”

*Emmanuel Colson, Managing Director at SimCorp Southern Europe,* commented: “The on-time and on-budget success of this project demonstrates SimCorp’s dedicated implementation resources while the system itself ensures our clients can benefit from the scale that is needed to support their growth. This is particularly important for asset managers with insurance mandates, where a low running cost and consolidated, multi-asset infrastructure is crucial in yielding desired returns. The collaboration between the teams has been great and we look forward to further strengthening this partnership in the future.”
 

*Enquiries regarding this announcement should be addressed to:
*Anders Crillesen, SimCorp Corporate Communications +45 3544 6474 anders.crillesen@simcorp.com
Mittal Shah, SimCorp UK/North America +44 207 397 8072 mittal.shah@simcorp.com
Anne Kermarrec, SimCorp Southern Europe +33 1 55 35 54 63 anne.kermarrec@simcorp.com
*
About SimCorp*
SimCorp provides integrated, best-in-class investment management solutions to the world’s leading asset managers, fund managers, asset servicers, pension and insurance funds, wealth managers and sovereign wealth funds. Whether deployed on premise or as an ASP solution, its core system, SimCorp Dimension, supports the entire investment value chain and range of instruments, all based on a market-leading IBOR. SimCorp invests more than 20% of its annual revenue in R&D, helping clients develop their business and stay ahead of ever-changing industry demands. Listed on NASDAQ Copenhagen, SimCorp is a global company, regionally covering all of Europe, North America, and Asia Pacific. For more information, please visit www.simcorp.com.

*About Groupama Asset Management  *
Since its creation in 1993 Groupama Asset Management, a subsidiary of Groupama, has established its place as one of the top French players in the field of asset management. Groupama Asset Management, which historically operated on behalf of numerous entities of the Groupama Group, has now put its expertise and know-how at the service of institutional investors, companies and distributors. For more information, please visit http://www.groupama-am.com. Reported by GlobeNewswire 44 minutes ago.

$21.7 Million Sports Bras Market - Global Shares, Market Strategies, and Market Forecasts, 2018-2024

September 6, 2018, 12:04 am

≫ Next: German industrial orders disappoint in July

≪ Previous: Groupama Asset Management Automates its Front and Middle Office Operations with SimCorp Dimension

$

0

0

Dublin, Sept. 06, 2018 (GLOBE NEWSWIRE) -- The "Sports Bras: Market Shares, Market Strategies, and Market Forecasts, 2018 to 2024" report from Wintergreen Research, Inc has been added to *ResearchAndMarkets.com's* offering.The shipments value of the sports bra market in 2017 at $6.49 million is rising to $21.7 million by 2024. In 2013, shipments of sports bras were $1.975 million representing significant growth.Growth is spurred by a rapid shift away from regular bras to the far more comfortable sports bra for all occasions except perhaps the most formal wear. The vendors in the sports bra industry have invested in high-quality technology and textured materials to develop leading-edge absorbency and flexibility of their bras.

There are a number of different sports bra designs that can be found in the on-line listings and in retail stores. The athleisure trend is here to stay because it provides significant health benefits. Improvements in comfort provided by sports bras have extended their use to all day. Sports bras represent a breakthrough in innovation and will likely completely replace traditional bras.

When working out, the bust is put through more stress and impacts than during daily activities. Breasts are subject to movements and bouncing that can create a force of up to five times their actual weight creating the possibility of tears. Wearing a sports bra provides both support and comfort needed when doing a physical activity.*Key Topics:*

· Sports Bras
· Low Impact Sports Bras
· Medium Impact Support Sports Bras
· High Impact Support Sports Bras
· Specialty Stores Sports Bras
· E-Commerce Sports Bras
· Sports Bras For Exercising
· Sports Bras For Running
· Sports Bras For Biking
· Sports Bras For Older Women
· Sports Bras For Hockey
· Sports Bras For Basketball

*Key Topics Covered:**1. Sports Bras: Market Description and Market Dynamics*
1.1 Female Runners
1.1.1 Respond Quickly To New Opportunities

*2. Sports Bras Market Shares and Forecasts*
2.1 Sports Bras Market Driving Forces
2.2 Sports Bra Market Shares
2.2.1 Sports Bra Competitive Markets
2.2.2 Sports Bras Company Market Positioning, Worldwide, 2017
2.3 Sports Bra Market Forecasts
2.4 Sports Bra Market Segment Analysis
2.4.1 Low, Medium, High Impact Sport Bras
2.4.2 Low Impact
2.4.3 Medium Support
2.4.4 High Impact Support
2.4.5 Market Analysis by Applications
2.4.6 Specialty Stores
2.4.7 E-commerce
2.5 Bra Market / Underwear Market
2.6 Sports Bra Prices
2.6.1 Nike
2.6.2 Lorna Jane Sports Bra Prices
2.7 Sports Bra Regional Analysis
2.7.1 Sports Bra US Regional Analysis
2.7.2 UK
2.7.3 Adidas Regional Revenue Growth
2.7.4 India

*3. Sports Bras Product Description*
3.1 Manufacturing Capacity

*4. Sports Bras Research and Technology*
4.1 When Women Are Exercising
4.2 Retailers Cater To Fitness-Focused Women
4.3 Victoria Secret Sports Bra

*5. Sports Bras Company Profiles*
5.1 Adidas
5.1.1 Adidas Sports Bras
5.1.2 Adidas Revenue
5.2 Aimer
5.2.1 Amir Singapore Brands
5.3 Anita
5.3.1 Anita Family Company
5.3.2 Anita Year-Long Campaign Showcasing 130 Women
5.3.3 Anita Revenue
5.4 Anta
5.4.1 Anta Chinese Sportswear
5.4.2 Anta The Sports Science Laboratory
5.4.3 Anta Revenue
5.5 Asics
5.5.1 Asics Institute in Kobe, Studying, Analyzing, Testing
5.5.2 ASICS Revenue
5.5.3 Asics Second Priority China
5.5.4 Asics Digital Commerce And Marketing
5.6 Berkshire Hathaway / Brooks Sports
5.6.1 Brooks Sports Revenue
5.7 Columbia Sportswear
5.7.1 Columbia Seasonality and Variability of Business
5.7.2 Columbia Manufacturing Planning
5.7.3 Columbia Revenue
5.8 Cosmo Lady
5.9 Decathlon
5.9.1 Decathlon Revenue
5.10 Fast Retailing
5.11 Gap
5.12 Hanes
5.12.1 Hanesbrands Revenue
5.12.2 Hanesbrands Sports Bra
5.12.3 Champion
5.12.4 Champion Revenue
5.13 L Brands
5.13.1 L Brands Revenue
5.13.2 L Brands Stores
5.14 Li-Ning
5.14.1 Li-Ning Revenue
5.15 Lorna Jane
5.15.1 Lorna Jane Revenue
5.16 Lululemon Athletica
5.16.1 Lululemon Athletica Revenue
5.17 New Balance
5.17.1 New Balance Running & Sports Bras
5.17.2 New Balance Revenue
5.17.3 New Balance Manufacturing
5.18 Nike
5.18.1 Nike Revenue
5.19 Puma
5.19.1 Puma Revenue
5.20 Reebok
5.20.1 Reebok Revenue
5.21 Triumph
5.21.1 Triumph International
5.22 Under Armour
5.22.1 Under Armour Sports Business
5.22.2 Under Armour Regional Segment Revenue
5.22.3 Under Armour Speed of Development and Manufacturing
5.23 VF Vanity Fair
5.23.1 VF Revenue
5.24 Wacoal
5.24.1 Wacoal Fit Consultants
5.24.2 Nursing Bras
5.24.3 Global Sleeping Bras

*6 Sports Bra Detailed Regional and Segment Analysis*
6.1 Americas
6.2 Europe
6.3 China
6.4 India
6.5 Japan
6.6 Southeast Asia
6.7 Korea
6.8 Sports Bra Market ParticipantsFor more information about this report visit https://www.researchandmarkets.com/research/vzgrqx/21_7_million?w=12

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Lingerie and Hosiery Reported by GlobeNewswire 44 minutes ago.

German industrial orders disappoint in July

September 6, 2018, 12:14 am

≫ Next: Optiv Security Announces Additional Key Appointments in Europe to Support International Growth Strategy

≪ Previous: $21.7 Million Sports Bras Market - Global Shares, Market Strategies, and Market Forecasts, 2018-2024

$

0

0

German industrial orders unexpectedly dipped again in July after a sharp drop in June, official data showed today, as global trade frictions cast a growing shadow over Europe's top economy. Reported by RTE.ie 34 minutes ago.

---

Optiv Security Announces Additional Key Appointments in Europe to Support International Growth Strategy

September 6, 2018, 12:09 am

≫ Next: Siam Canadian Group Launches Meat Division, Aiming to Enter into New Market

≪ Previous: German industrial orders disappoint in July

$

0

0

LONDON & DENVER--(BUSINESS WIRE)--#CyberSecurity--Optiv Security today announced two key appointments in Europe to support its international growth strategy. Reported by Business Wire 39 minutes ago.

Siam Canadian Group Launches Meat Division, Aiming to Enter into New Market

September 6, 2018, 12:15 am

≫ Next: Earlybird, ABN AMRO Digital Impact Fund and solarisBank invest in CrossLend

≪ Previous: Optiv Security Announces Additional Key Appointments in Europe to Support International Growth Strategy

$

0

0

BANGKOK, Sept. 6, 2018 /PRNewswire/ -- Siam Canadian, well known over the past 30 years as a major Asian based global frozen seafood supplier has now upped its interest in the frozen meat business and officially established a new entity, *Siam Canadian -- Meat Division  *www.siamcanadianmeat.com. The new division is headed by Ms. Justyna Popielska, who will be based in her home town of Szczecin, Poland. Justyna as General Manager of the division is tasked with driving the growth of the meat business.Ms. Justyna Popielska, General Manager - Meat Division, Siam Canadian Group

Jim Gulkin, Siam Canadian's Group Managing Director explained, "the objective of the new division is to quickly build a significant position in the meat industry much in the same way that Siam Canadian has already realized in the frozen seafood sector. I am confident Justyna will achieve this and we will aggressively continue to grow the meat division as we go forward."

Justyna Popielska brings with her a wealth of experience trading in a wide range of meat products, sourcing from a broad group of top quality suppliers in South America, North America, Europe as well as Asia to established buyers in Asia and beyond. This combined with Siam Canadian's existing network of suppliers and customers gives the Meat Division a strong base to build on.

"Siam Canadian has a record of success proven over the past 30 plus years. Our current annual sales exceed USD 325 million and I am confident that the new Meat Division and a European presence will help fuel Siam Canadian's further growth and diversification into new markets," Richard Williams, Siam Canadian's Director of Group Business Development added.

*About Siam Canadian Group Limited*

Siam Canadian, established in 1987 has grown continuously for the past 30 years. Last year, Siam Canadian Group, which is headquartered in Bangkok, Thailand, shipped over 3,000 containers of product valued at over USD 325 million. Siam Canadian sells to importers, wholesalers, retailers and distributors in over 70 countries, supplying a wide range of frozen seafood from its branches in Thailand, China, Vietnam, Indonesia, India and Myanmar as well as Bangladesh. Although primarily exporting frozen seafood, Siam Canadian also exports frozen fruit, vegetables, canned products as well as high quality meats and poultry. For more information, please visit https://www.siamcanadian.com/.

For more information, please contact:

*Siam Canadian Group Limited*

*Penner-Madison & Company Limited*

*Piyaporn Yoopumepruek*

*Chupit Chutitum*

+66-21853311

+66-818281839

bow@siamcanadian.com 

chupit_g@penner-madison.com       

Photo - https://photos.prnasia.com/prnh/20180906/2230069-1

Related Links :

https://www.siamcanadian.com/ Reported by PR Newswire Asia 34 minutes ago.

Earlybird, ABN AMRO Digital Impact Fund and solarisBank invest in CrossLend

September 6, 2018, 12:26 am

≫ Next: The importance of periodic vehicle emission tests for air quality [Promoted content]

≪ Previous: Siam Canadian Group Launches Meat Division, Aiming to Enter into New Market

$

0

0

DGAP-News: BrunoMedia GmbH / Key word(s): Financing

06.09.2018 / 09:15
The issuer is solely responsible for the content of this announcement.
--------------------
 

- The B2B FinTech company CrossLend raises EUR14 million in the recent funding round led by Earlybird Venture Capital and ABN AMRO's Digital Impact Fund (DIF)

- Berlin-based banking platform solarisBank has also previously invested in CrossLend

- Existing investors, including early backer Lakestar and the Luxembourg Future Fund re-invest

- Besides the investment, solarisBank and ABN AMRO have also entered into strategic partnerships with CrossLend

- The new investment and the strategic partnerships will further power CrossLend's growth and accelerate its mission of making the global debt ecosystem more efficient, transparent, and profitable

CrossLend, a digital marketplace for loans, today announced the closing of a EUR 14 million financing round under participation of new investors Earlybird Venture Capital, ABN AMRO's Digital Impact Fund (DIF), and solarisBank, as well as renewed commitments from existing investors such as the Luxembourg Future Fund and Lakestar.

ABN AMRO's investment is part of a strategic partnership with CrossLend. Likewise, Berlin-based solarisBank, which is also backed by venture firm Lakestar, and CrossLend have recently started a cooperation to offer fully digital and automated loan securitization. With both strategic partnerships and the new funding, the only four-year-old company is on its way to establishing a European Debt Exchange.

"We are extremely proud to have Earlybird, ABN AMRO, and solarisBank joining our existing investor base. We are partnering with precisely the type of investors we need to grow our business further and continue to implement our mission of making the global debt ecosystem more efficient, transparent, and profitable. Our products help banks to regain profitability while simultaneously helping borrowers to access better financing opportunities," says Oliver Schimek, CEO of CrossLend.

CrossLend is working in line with the European Commission's plan to create a European Capital Markets Union that will provide funding flows to address the economy's needs. Despite several initiatives by the European Commission, significant obstacles to creating an optimized flow of funds remain - CrossLend's business model aims to remove these hurdles.

"In the past, most FinTech-driven innovations targeted the interaction between customers and financial products. But we believe that in times of regulatory pressure, a smarter refinancing backend for the European banking industry is urgently required to enable the institutions to provide better services to their customers and at the same time leverage more of their resources. Our vision is to give people more control over the use of their creditworthiness," adds Oliver Schimek, CEO of CrossLend.

Christian Nagel, Earlybird partner, comments: "We are excited about CrossLend's vision to transform from a digital investment bank model to a fully-fledged debt exchange. We strongly believe that their plan to tokenize debt items and hence introduce blockchain-based settlements will lead to more transparent loan books and at the same time more efficient debt capital markets. Global borrowers, regardless if they are SMEs or direct consumers, will benefit as markets will become more liquid. Billions of additional capital for SME financing could be unleashed - solving one of the major global issues in financial markets."

Hugo Bongers, Director at ABN AMRO's Digital Impact Fund, comments: "There is a clear business opportunity in making more capital available for companies via CrossLend's proven platform that already has significant commercial traction. CrossLend's digital platform is very efficient in making capital available in cross-border European markets. We believe that this solution will set a possible new industry standard. In addition, this investment further broadens and strengthens our local relationships in Germany, being one of the leading FinTech countries in Europe."

*About CrossLend:*
Founded in Berlin in 2014 in Berlin and Luxembourg, CrossLend is a digital marketplace for loans. As a B2B FinTech company, CrossLend's mission is to make the global debt ecosystem more efficient, transparent and profitable. By means of an innovative securitisation setup, investors can flexibly build diversified portfolios of loans (via notes) at a pan-European level, with an emphasis on providing risk transparency. On the other hand, loan originators profit from flexible opportunities to scale their lending business - opening up much-needed financing avenues to small and medium-sized businesses across Europe. A win-win-win situation for all. Backed by an array of prestigious equity investors from Europe and the U.S., including Lakestar, CME Ventures, Earlybird, ABN AMRO's Digital Impact Fund, solarisBank, and the Luxembourg Future Fund, CrossLend plans to establish a European Debt Exchange. In Germany, CrossLend acts as tied agent of FinTech Group Bank AG within the scope of § 2 para. 10 of the German Banking Act.
www.crosslend.com

*About Earlybird:*
Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. Earlybird manages different funds with focuses on digital technologies in Eastern and Western Europe as well as health technologies. With over EUR 1 billion under management, seven IPOs and, 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe.

For further information:
www.earlybird.com
Twitter: http://www.twitter.com/EarlybirdVC
LinkedIn: www.linkedin.com/company/earlybird-venture-capital
or Facebook: www.facebook.com/EarlybirdVC

*About solarisBank:*
solarisBank is the first banking platform with a full banking license which enables companies to offer their own financial products. Through APIs, partners gain access to solarisBank's modular services including payments and e-money, lending, digital banking as well as services provided by integrated third party providers. Through this, solarisBank creates a highly developed technological banking ecosystem for FinTechs, established digital companies, as well as banks and corporates.
The Berlin-based company was founded back in 2016 and is led by CEO Dr. Roland Folz, board members Marko Wenthin and Andreas Bittner, as well as CFO Alexander Engel and CPO Dr. Jörg Howein. To date, solarisBank has raised more than EUR 95 million from renowned investors, including BBVA, Visa, Lakestar, ABN AMRO's Digital Impact Fund, Arvato Financial Solutions, SBI Group, Finleap and yabeo.
www.solarisbank.de

*About ABN Amro Digital Impact Fund:*
ABN AMRO's Digital Impact Fund (DIF) is our corporate venture capital fund specifically for FinTech. ABN AMRO uses this fund for our strategic investments in innovative startups and scale-ups that digitalise financial products and services. Besides CrossLend, the fund has six other portfolio companies: German based solarisBank, Dutch Ockto, US Cloud Lending Solutions and BehavioSec, Tink in Sweden and blockchain initiatief in trade & commodity finance.
www.abnamro.nl

*About Lakestar:*
Lakestar is one of Europe's leading venture capital firms investing in technology companies led by exceptional entrepreneurs. Early investments included Skype, Spotify, Facebook and airbnb. Since raising their last two funds with an aggregate volume of approx. EUR 500m in 2013 and 2015, Lakestar has expanded and broadened their portfolio, with more recent investments in Harry's, Opendoor, Blockchain.com, GoEuro, FiveAI and Revolut. Lakestar has presence in Berlin, Zurich and London. Lakestar helps companies to identify new markets and expand into them rapidly, with a focus on the US and Europe. They advise and support portfolio companies in business development, recruitment, technology and marketing. The investments range from early stage companies to those in their growth stage.
www.lakestar.com

*Press contact:*
Ralf-Dieter Brunowsky
BrunoMedia GmbH
Phone: 06131 9302830
Mail: brunowsky@brunomedia.de

 
--------------------

06.09.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de -------------------- Reported by EQS Group 22 minutes ago.

The importance of periodic vehicle emission tests for air quality [Promoted content]

September 6, 2018, 10:01 pm

≫ Next: Passengers fall ill on two flights from Europe

≪ Previous: Earlybird, ABN AMRO Digital Impact Fund and solarisBank invest in CrossLend

$

0

0

Many cities in Europe have problems because they exceed the current limits for air pollutants. Some of them are even considering banning diesel vehicles in general to batten down the hatches, writes Gerhard Müller. Reported by EurActiv 3 hours ago.

Passengers fall ill on two flights from Europe

September 6, 2018, 9:57 pm

≫ Next: Macron Seeks New ‘Progressive’ Coalition For 2019 European Elections

≪ Previous: The importance of periodic vehicle emission tests for air quality [Promoted content]

$

0

0

No one on either plane was quarantined. Reported by Khaleej Times 3 hours ago.